Keratoconus News and Research

RSS

Study reveals another clue to workings of trachoma

Another clue to the workings of trachoma - the world's leading infectious cause of blindness - has been revealed in a new study published in BMC Infectious Diseases. Researchers identified markers of genetic regulation present in the early stages of infection that could predispose children to developing the condition in its long-term, severe form.

17 Feb 2016

New clinical study reveals previously unknown risk factors linked to keratoconus

A large new study reveals previously unknown risk factors associated with an eye condition that causes serious progressive nearsightedness at a relatively young age.

13 Jan 2016

Laser eye surgery: a glimpse into the future - An interview with Professor Dan Reinstein

LASIK (Laser In Situ Keratomileusis) creates a hinged flap with a microkeratome and evaporating corneal tissue under the flap with an excimer laser. However, the concept that refractive error could be corrected by sculpting corneal stromal tissue to change corneal curvature was the brainchild of Jose Ignacio Barraquer Moner in 1948.

9 Aug 2015

Gene therapy provides life-long protection to photoreceptor cells in animal model of retinitis pigmentosa

A collaboration between scientists in the UK and the USA has shown that gene therapy can give life-long protection to the light-sensitive photoreceptor cells responsible for colour vision in a mouse model of the most common inherited eye disorder.

15 Jul 2015

Leading causes of blindness can be detected by looking at how eyes respond to watching TV

One of the leading causes of blindness worldwide could be detected by how our eyes respond to watching TV according to a new study from researchers at City University London.

11 Nov 2014

New approach to measuring, correcting visual abnormalities

A technique developed by astronomers seeking a clear view of distant objects in space is being intensively studied as a new approach to measuring and correcting visual abnormalities.

25 Sep 2014

Avedro receives Canadian approval for KXL II System

Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company announces today the Canadian approval for the company's KXL II System. The KXL II System performs a procedure called PiXL (Photorefractive Intrastromal Cross-Linking) which has the potential to deliver non-surgical correction of myopia, and improve cataract surgery outcomes.

23 Apr 2014

Tips to avoid eye irritation and longer-term damage to eyes during allergy season

With the advent of spring comes wind and allergy season, which can prove to be challenging for individuals who rely on contact lenses for clearer vision. According to the Asthma and Allergy Foundation of America, approximately 1 out of 5 individuals in the United States suffer from eye allergies, while nearly half of all individuals who wear contact lenses report irritation and discomfort from wearing contacts during allergy season.

25 Mar 2014

Nutrition and exercise have significant impact on one's vision

With the New Year comes many resolutions, including resolving to exercise more and eat better. While many individuals understand that nutrition and exercise play an important role in helping to prevent diabetes, obesity, and cardiovascular disorders, not many may be aware that these two elements have a significant impact on one's vision as well. Dr. Sandy T. Feldman, a renowned ophthalmologist and corneal expert at Clearview Eye & Laser Center in San Diego, advises patients to examine their physical fitness and eating habits in order to achieve optimum vision.

11 Feb 2014

FDA grants priority review status to Avedro's riboflavin ophthalmic solution/KXL system

Avedro Inc, a Boston-based ophthalmic medical device and pharmaceutical company announces that it received notification from the U.S. Food and Drug Administration stating that their NDA for riboflavin ophthalmic solution/KXL system has been filed, and has been granted priority review status. The priority review status places the application action date at March 15th, 2014.

25 Nov 2013

Avedro initiates US clinical trials for Lasik with cross-linking and pulsed accelerated cross-linking

Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.

12 Nov 2013

Statins may increase risk of cataracts among individuals above 30 years old

According to the Centers for Disease Control and Prevention, cataracts are the number one cause of vision loss in the United States. Nearly 22 million Americans age 40 and over have cataracts, while more than half of individuals age 80 and over suffer from this condition. In a recent study released in JAMA Ophthalmology, it was confirmed that statins, which are typically prescribed to reduce cholesterol and also prevent heart disease, may cause an increased risk for cataracts among individuals ages 30 through 85.

14 Oct 2013

University of Nottingham scientists discover previously undetected layer in the cornea

Scientists at The University of Nottingham have discovered a previously undetected layer in the cornea, the clear window at the front of the human eye.

11 Jun 2013

Eye-rubbing may provoke, aggravate keratoconus

Rubbing the eyes leads to an increase in protease activity and levels of protease and inflammatory mediators, a clinical study shows.

1 Mar 2013

Clearview announces arrival of Catalys Precision Laser System in Southern CA

Clearview Eye & Laser Medical Center announces the arrival of the world's most sophisticated laser cataract surgery system in Southern CA.

24 Feb 2013

Study identifies genes for central corneal thickness that may cause eye conditions

Scientists at Singapore Eye Research Institute and A*STAR's Genome Institute of Singapore have succeeded in identifying genes for central corneal thickness that may cause potentially blinding eye conditions. These eye conditions include glaucoma, as well as the progressive thinning of the cornea, which may eventually lead to a need for corneal transplantation.

17 Jan 2013

Researchers develop glue mixture that may reduce risks after laser vision correction surgery

Kansas State University researchers have developed a glue mixture that may reduce risks after laser vision correction surgery.

28 Aug 2012

Acne pills can cause eye infections

Millions of teenagers suffer from acne, and they deal with the embarrassing skin blemishes by taking popular prescription medications such as Accutane or Roaccutane. Now, however, research from Tel Aviv University shows that these pills can also cause eye infections such as conjunctivitis (pink eye) or sties.

24 May 2012

Cleveland Eye Clinic surgeons perform Corneal Cross-Linking procedure

For years, patients with an eye disease called keratoconus have had little to no hope of continuing to see well without glasses or contacts, and a portion of them had a high risk corneal transplant in their future. Keratoconus is an eye disease that causes the cornea (the clear covering on the eye) to become thin and steep over time. Patients with keratoconus can wear special contact lenses or in some cases glasses. Many of them lose the ability to see well even with corrective eye wear.

18 May 2012

Avedro, ACOS commence accelerated corneal cross-linking Phase 3 study

ACOS and Avedro, Inc. jointly announced today the initiation of a Phase 3, multi-center, randomized, controlled evaluation to study accelerated corneal collagen cross-linking in eyes with keratoconus or corneal ectasia after refractive surgery.

3 Apr 2012